[1]
V. Sharma, S. Chawla, S. Garg, and B. Singh, “Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus: An open-label comparative study”, Sultan Qaboos Univ Med J, vol. 24, no. 2, pp. 243–249, May 2024.